Yuki Iida
ORCID: 0000-0001-9714-3013
· 6 papers in corpus
observational
2026
PURPOSE: To characterize early learning curves for two gynecologic oncologists and their first assistants using the Hugo robotic-assisted surgery system for hysterectomy in benign uterine disease or FIGO stage IA endometrial cancer. METHOD…
lab-animal
2025
We aimed to generate immortalized stromal cell lines from the ovarian and fallopian tube tissues of a single patient using Sendai virus (SeV) vectors and identify candidate stromal genes involved in ovarian carcinogenesis. Tissues were coll…
other
2025
BACKGROUND: This study evaluated the effectiveness of preoperative inflammatory response markers in distinguishing clear cell carcinoma (CCC) and endometrioid carcinoma (EC) from ovarian endometrioma. METHODS: Patients with stage I ovarian…
case-report
2023
Malignant pericardial effusion is an uncommon metastatic manifestation of ovarian carcinoma. Few cases of ovarian serous carcinoma have been previously reported. Ovarian clear cell carcinoma is the second most common histologic subtype in E…
observational
2023
AIM: This study aimed to compare introduced robotic-assisted hysterectomy (RAH) and skilled total laparoscopic hysterectomy (TLH) for the treatment of benign gynecological diseases. METHODS: Patients who underwent RAH or TLH by two surgeon…
observational
2021
PURPOSE: To investigate the role of estrogen receptors (ERs) in high-grade serous carcinoma (HGSC) and clear cell carcinoma (CCC) of the ovary and evaluate ERs as prognostic biomarkers for ovarian cancer. METHODS: This study included 79 pa…